Skip to main content
Veterinary Medicines

VECOXAN 2.5 MG/ML ORAL SUSPENSION

Authorised
  • Diclazuril

Product identification

Medicine name:
VECOXAN 2.5 MG/ML ORAL SUSPENSION
Vecoxan 2.5 mg/ml Suspensie voor oraal gebruik
Vecoxan 2.5 mg/ml Suspension buvable
Vecoxan 2.5 mg/ml Suspension zum Einnehmen
Active substance:
  • Diclazuril
Target species:
  • Cattle (calf)
  • Sheep (lamb)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Diclazuril
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC03
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET PRODUCTIONS
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V210612
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0113/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Slovakia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/06/2024
French (PDF)
Published on: 6/06/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/06/2024
French (PDF)
Published on: 6/06/2024
German (PDF)
Published on: 6/06/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."